ARTBIO Raises Oversubscribed and Upsized $90 Million Series A Financing to Progress Pipeline and Isotope Technology Development for New Class of Alpha Radioligand Therapies

ARTBIO United Kingdom Norway Switzerland Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/artbio-raises-oversubscribed-and-upsized-90-million-series-a-financing-to-progress-pipeline-and-isotope-technology-development-for-new-class-of-alpha-radioligand-therapies-302008233.html